Kidney cancer is among the most lethal of urologic malignancies. The rising incidence of kidney cancer is attributable to greater detection of incidental small renal masses (≤4 cm) from increased use ...

Please provide your email address to receive an email when new articles are posted on . Lower rates of adverse outcomes were linked to higher technical skill Surgeons with higher scores had lower ...

The recently developed single-port, multichannel access approach to urologic surgery may allow many common laparoscopic and robotic procedures to be performed entirely through the patient’s umbilicus, ...

Robotic surgery has become a leading option for various surgical procedures in recent years, both malignant and benign. Procedures such as radical prostatectomy, partial nephrectomy, and radical ...

Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, according to Dr. Armine Smith. Robotic and minimally invasive surgery for ...

A surgeon at Tygerberg Hospital in Cape Town has performed a first in South Africa. Urologist Dr Danelo du Plessis successfully performed a donor nephrectomy — a surgical procedure to remove a kidney ...

With FDA clearance, the Hugo RAS system is indicated for use in minimally invasive urologic surgical procedures including prostatectomy, nephrectomy, and cystectomy — common procedures that account ...

Single‐port robotic surgery represents a significant advance in minimally invasive urology. This technique employs a dedicated robotic platform through a single incision, thereby reducing surgical ...

Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.

Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage ...

Medtronic has announced that the U.S. Food and Drug Administration (FDA) has cleared the Hugo robotic-assisted surgery (RAS) ...